Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy
New York Times
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.
https://www.nytimes.com/2023/08/28/business/denmark-ozempic-wegovy.html